{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:10:38Z","timestamp":1774321838907,"version":"3.50.1"},"reference-count":24,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2020,11,8]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Clinical assessment of patients with mild traumatic brain injury (mTBI) is challenging and overuse of head CT in the ED is a major problem. Several studies have attempted to reduce unnecessary head CTs following a mTBI by identifying new tools aiming to predict intracranial bleeding. Higher levels of S100B protein have been associated with intracranial haemorrhage following a mTBI in previous literature. The main objective of this study is to assess whether plasma S100B protein level is associated with clinically significant brain injury and could be used to reduce the number of head CT post-mTBI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>Study design:<\/jats:italic>secondary analysis of a prospective multicentre cohort study conducted between 2013 and 2016 in five Canadian EDs.<jats:italic>Inclusion criteria:<\/jats:italic>non-hospitalised patients with mTBI with a GCS score of 13\u201315 in the ED and a blood sample drawn within 24\u2009hours after the injury.<jats:italic>Data collected:<\/jats:italic>sociodemographic and clinical data were collected in the ED. S100B protein was analysed using ELISA. All CT scans were reviewed by a radiologist blinded to the biomarker results.<jats:italic>Main outcome:<\/jats:italic>the presence of clinically important brain injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>476 patients were included. Mean age was 41\u00b118 years old and 150 (31.5%) were women. Twenty-four (5.0%) patients had a clinically significant intracranial haemorrhage. Thirteen patients (2.7%) presented a non-clinically significant brain injury. A total of 37 (7.8%) brain injured patients were included in our study. S100B median value (Q1\u2013Q3) was: 0.043\u2009\u00b5g\/L (0.008\u20130.080) for patients with clinically important brain injury versus 0.039\u2009\u00b5g\/L (0.023\u20130.059) for patients without clinically important brain injury. Sensitivity and specificity of the S100B protein level, if used alone to detect clinically important brain injury, were 16.7% (95% CI 4.7% to 37.4%) and 88.5% (95% CI 85.2% to 91.3%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Plasma S100B protein level was not associated with clinically significant intracranial lesion in patients with mTBI.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2020-209583","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T23:25:46Z","timestamp":1608679546000},"page":"285-289","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: a subanalysis of a prospective cohort study"],"prefix":"10.1136","volume":"38","author":[{"given":"Julien","family":"Blais L\u00e9cuyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier-Alexandre","family":"Tardif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M","family":"Archambault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Chauny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0372-0586","authenticated-orcid":false,"given":"Simon","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Frenette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Stiell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"\u00c9mond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddy","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2743-4290","authenticated-orcid":false,"given":"Andrew","family":"McRae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4762-8156","authenticated-orcid":false,"given":"Natalie","family":"Le Sage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"2025062300501710000_38.4.285.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04561-X"},{"key":"2025062300501710000_38.4.285.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-003-0115-1"},{"key":"2025062300501710000_38.4.285.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.12.1519"},{"key":"2025062300501710000_38.4.285.4","first-page":"483","article-title":"Ct overuse for mild traumatic brain injury","volume":"38","author":"Melnick","year":"2012","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"2025062300501710000_38.4.285.5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3109\/02699052.2015.1037349","article-title":"S100B protein as a screening tool for computed tomography findings after mild traumatic brain injury: systematic review and meta-analysis","volume":"29","author":"Heidari","year":"2015","journal-title":"Brain Inj"},{"key":"2025062300501710000_38.4.285.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000209534.61058.35"},{"key":"2025062300501710000_38.4.285.7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1515\/cclm-2013-0621","article-title":"S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study","volume":"52","author":"Laribi","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2025062300501710000_38.4.285.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2011.07.027"},{"key":"2025062300501710000_38.4.285.9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/02699052.2011.635360","article-title":"Accuracy of the S100\u03b2 protein as a marker of brain damage in traumatic brain injury","volume":"26","author":"Egea-Guerrero","year":"2012","journal-title":"Brain Inj"},{"key":"2025062300501710000_38.4.285.10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1089\/neu.2013.2853","article-title":"Classification accuracy of serum apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan","volume":"30","author":"Bazarian","year":"2013","journal-title":"J Neurotrauma"},{"key":"2025062300501710000_38.4.285.11","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2000.17.113"},{"key":"2025062300501710000_38.4.285.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0533-y"},{"key":"2025062300501710000_38.4.285.13","article-title":"Blood-Based protein biomarkers for the management of traumatic brain injuries in adults presenting to emergency departments with mild brain injury: a living systematic review and meta-analysis","author":"Mondello","year":"2018","journal-title":"J Neurotrauma"},{"key":"2025062300501710000_38.4.285.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017848"},{"key":"2025062300501710000_38.4.285.15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00701-016-3046-3","article-title":"A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury","volume":"159","author":"Thelin","year":"2017","journal-title":"Acta Neurochir"},{"key":"2025062300501710000_38.4.285.16","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1515\/cclm-2018-0471","article-title":"Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients","volume":"56","author":"Allouchery","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2025062300501710000_38.4.285.17","doi-asserted-by":"publisher","DOI":"10.1097\/HTR.0b013e3181e57e22"},{"key":"2025062300501710000_38.4.285.18","unstructured":"EPA US . Guidance for data quality assessment: practical methods for data analysis EPA QA\/G-9 QUW. DC: US: Environmental Protection Agency, 2000."},{"key":"2025062300501710000_38.4.285.19","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2006.23.149"},{"key":"2025062300501710000_38.4.285.20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-211-98811-4_46","article-title":"Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury","volume":"106","author":"Kleindienst","year":"2010","journal-title":"Acta Neurochir Suppl"},{"key":"2025062300501710000_38.4.285.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1757"},{"key":"2025062300501710000_38.4.285.22","article-title":"Performance evaluation of a multiplex assay for simultaneous detection of four clinically relevant traumatic brain injury biomarkers","author":"Korley","year":"2018","journal-title":"J Neurotrauma"},{"key":"2025062300501710000_38.4.285.23","first-page":"605","volume-title":"Comparison of emergency department time performance between a Canadian and an Australian academic tertiary hospital","volume":"31","author":"Cheng","year":"2019"},{"key":"2025062300501710000_38.4.285.24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11739-019-02051-1","article-title":"Emergency department visits by patients with an internal medicine specialist: understanding the role of specialists in reducing ED crowding","volume":"14","author":"Aaronson","year":"2019","journal-title":"Intern Emerg Med"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2020-209583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T07:50:53Z","timestamp":1750665053000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2020-209583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,3,19]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/emermed-2020-209583"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2020-209583","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}